Volume Control in Hemodialysis Patients.

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Hypertension

Background:

• Cardiovascular disease (CVD) is a primary cause of mortality in dialysis patients, often linked to inadequate blood pressure (BP) management.
• Normalizing extracellular volume (ECV) is essential for achieving stable blood pressure (normotension).
• The concept of dry weight links ECV and BP, defining an ideal postdialysis weight for maintaining normotension without antihypertensive drugs.

Purpose of the Study:

• To explore the challenges and strategies associated with achieving and maintaining dry weight in dialysis patients.
• To highlight the importance of ECV and BP control for improving outcomes in patients undergoing dialysis.
• To discuss factors influencing the effectiveness of the dry weight method for hypertension management.

Main Methods:

• Clinical evaluation considering factors like nutritional status, symptom variability, and time lags between ECV and BP changes.
• Management of ECV through dietary salt restriction to minimize interdialytic weight gain (saline overload).
• Utilizing dialysis sessions for diffusive and convective removal of salt and water.

Main Results:

• Clinical assessment of dry weight is complicated by variable patient weight, nonspecific symptoms, and delayed BP responses to ECV shifts.
• Factors hindering dry weight achievement include short dialysis sessions, high interdialytic weight gain, antihypertensive medications, and cardiac comorbidities.
• Extended dialysis session times facilitate slower, more manageable ultrafiltration, aiding in achieving target dry weight.

Conclusions:

• Effective management of extracellular volume and blood pressure through dry weight optimization is critical for reducing mortality in dialysis patients.
• Addressing confounding clinical factors and optimizing dialysis parameters, such as session length, are key to successful dry weight achievement.
• A comprehensive approach integrating dietary salt control, appropriate ultrafiltration, and careful clinical monitoring is necessary for managing hypertension in this population.